These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2193365)

  • 1. [Physiology of the portal system and physiopathology of portal hypertension].
    Lebrec D
    Rev Prat; 1990 Jun; 40(16):1450-3. PubMed ID: 2193365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splanchnic hemodynamics in idiopathic portal hypertension: comparison with chronic persistent hepatitis.
    Ohnishi K; Sato S; Nomura F; Iida S
    Am J Gastroenterol; 1989 Apr; 84(4):403-8. PubMed ID: 2929561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of portal hypertension].
    Montaño-Loza A; Meza-Junco J
    Rev Invest Clin; 2005; 57(4):596-607. PubMed ID: 16315644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of portal hypertension.
    Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic portal hypertension and its pathology.
    Okudaira M; Ohbu M; Okuda K
    Semin Liver Dis; 2002 Feb; 22(1):59-72. PubMed ID: 11928079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal hypertension: state of the art.
    Gatta A; Sacerdoti D; Bolognesi M; Merkel C
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):326-45. PubMed ID: 10425579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
    Wang CT; Kuang YL; Chen ZP
    Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic and progressive increase of portal venous pressure on renal handling of water and electrolytes in rats.
    Blanchart A; Fernández-Muñoz D; Caramelo C; Hernando L; López-Novoa JM
    Miner Electrolyte Metab; 1985; 11(5):295-300. PubMed ID: 3900673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
    Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
    Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperdynamic circulation in portal hypertension: a comparative model of arterio-venous fistula.
    Wattanasirichaigoon S; Gordon FD; Resnick RH
    Med Hypotheses; 2000 Jul; 55(1):77-87. PubMed ID: 11021333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of liver circulation with an overview of medical and invasive treatments.
    Bombardieri G; Conti LR
    Rays; 1997; 22(2):196-210. PubMed ID: 9351328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental observation of high portal venous resistance in dogs].
    Wang WM
    Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):349-51, 381. PubMed ID: 8258105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].
    Albornoz L; Bandi JC; Sánchez S; Spinedi E; Canteros G; De Paula JA; Galdame O; Mastai R
    Medicina (B Aires); 1994; 54(1):17-24. PubMed ID: 7990681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
    Shah V
    J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
    Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D
    Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.